Lipid Nanoparticle-Mediated Hit-and-Run Approaches Yield Efficient and Safe In Situ Gene Editing in Human Skin
Authors:
Open Access
- 2 November 2023
- journal article
- research article
- Published by American Chemical Society (ACS) in ACS Nano
- Vol. 17 (21) , 22046-22059
Abstract
Despite exciting advances in gene editing, the efficient delivery of genetic tools to extrahepatic tissues remains challenging. This holds particularly true for the skin, which poses a highly restrictive delivery barrier. In this study, we ran a head-to-head comparison between Cas9 mRNA or ribonucleoprotein (RNP)-loaded lipid nanoparticles (LNPs) to deliver gene editing tools into epidermal layers of human skin, aiming for in situ gene editing. We observed distinct LNP composition and cell-specific effects such as an extended presence of RNP in slow-cycling epithelial cells for up to 72 h. While obtaining similar gene editing rates using Cas9 RNP and mRNA with MC3-based LNPs (10-16%), mRNA-loaded LNPs proved to be more cytotoxic. Interestingly, ionizable lipids with a pKa ∼ 7.1 yielded superior gene editing rates (55%-72%) in two-dimensional (2D) epithelial cells while no single guide RNA-dependent off-target effects were detectable. Unexpectedly, these high 2D editing efficacies did not translate to actual skin tissue where overall gene editing rates between 5%-12% were achieved after a single application and irrespective of the LNP composition. Finally, we successfully base-corrected a disease-causing mutation with an efficacy of ∼5% in autosomal recessive congenital ichthyosis patient cells, showcasing the potential of this strategy for the treatment of monogenic skin diseases. Taken together, this study demonstrates the feasibility of an in situ correction of disease-causing mutations in the skin that could provide effective treatment and potentially even a cure for rare, monogenic, and common skin diseases.Keywords
Funding Information
- Canadian Institutes of Health Research (CIHR PJT-166035)
- LEO Fondet (LF-OC-22-000954)
- Schweizerischer Nationalfonds zur Förderung der Wissenschaftlichen Forschung (183923)
- Faculty of Pharmaceutical Sciences, University of British Columbia
- NanoMedicines Innovation Network
- Stiftung Charité
This publication has 90 references indexed in Scilit:
- Topical treatment of ichthyosesDermatologic Therapy, 2013
- Transcutaneous vaccination via laser microporationJournal of Controlled Release, 2012
- Maximizing the Potency of siRNA Lipid Nanoparticles for Hepatic Gene Silencing In Vivo**Angewandte Chemie International Edition, 2012
- Influence of Cationic Lipid Composition on Gene Silencing Properties of Lipid Nanoparticle Formulations of siRNA in Antigen-Presenting CellsMolecular Therapy, 2011
- Characterization of Microchannels Created by Metal Microneedles: Formation and ClosureThe AAPS Journal, 2011
- Revised nomenclature and classification of inherited ichthyoses: Results of the First Ichthyosis Consensus Conference in Sorèze 2009Journal of the American Academy of Dermatology, 2010
- Targeted Delivery of RNAi Therapeutics With Endogenous and Exogenous Ligand-Based MechanismsMolecular Therapy, 2010
- Transglutaminase-1 and Bathing Suit Ichthyosis: Molecular Analysis of Gene/Environment InteractionsJournal of Investigative Dermatology, 2009
- Transglutaminase-1 gene mutations in autosomal recessive congenital ichthyosis: Summary of mutations (including 23 novel) and modeling of TGase-1Human Mutation, 2009
- LDL Receptors in KeratinocytesJournal of Investigative Dermatology, 1992